TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.20$ -1.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZYBT
Line item 2021 2022 2023 2024 2025
– -45.5% +178.0% -14.8% -67.5%
– +17.4% +27.2% +1.0% +7.4%
– – – – –
– +3.5% -57.6% +139.4% -54.5%
– +4.0% -56.9% – –
– +93.9% +84.1% -59.4% +0.0%
– +336.0% -28.4% -111.0% +341.7%
– – -241.1% +16.6% –
– +39.1% +403.8% -149.2% –
– -284.7% – -63.7% -94.7%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?